Information:
Fel:
ID
26209
Beskrivning
Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00661531
Länk
https://clinicaltrials.gov/show/NCT00661531
Nyckelord
Versioner (1)
- 2017-10-11 2017-10-11 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
11 oktober 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Cancer NCT00661531
Eligibility Breast Cancer NCT00661531
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00661531
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Oestrogen receptor positive breast cancer | Breast Carcinoma Progesterone receptor positive | Secondary malignant neoplasm of female breast
Item
histologically confirmed estrogen and/or progesterone receptor-positive breast cancer metastatic breast cancer
boolean
C2938924 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])
C0346993 (UMLS CUI [3])
C0678222 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])
C0346993 (UMLS CUI [3])
Evaluable Disease
Item
clinically determined evaluable disease
boolean
C1516986 (UMLS CUI [1])
Postmenopausal state
Item
post-menopausal woman
boolean
C0232970 (UMLS CUI [1])
Benefit clinical Due to Prior antiestrogen therapy | Hormone Therapy Quantity failed
Item
previous clinical benefit from prior anti-estrogen therapies and subsequent failure of at least 2 prior endocrine therapies.
boolean
C0814225 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0279797 (UMLS CUI [1,4])
C0279025 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
C0205210 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0279797 (UMLS CUI [1,4])
C0279025 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
Chemotherapy Disease Adjuvant Induced | Chemotherapy Neoplasm Metastasis
Item
may have had chemotherapy for adjuvant &/or metastatic disease.
boolean
C0392920 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0001552 (UMLS CUI [1,3])
C0205263 (UMLS CUI [1,4])
C0392920 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
C0012634 (UMLS CUI [1,2])
C0001552 (UMLS CUI [1,3])
C0205263 (UMLS CUI [1,4])
C0392920 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
Therapeutic radiology procedure | Exception Disease Site only
Item
may have had radiation therapy but not to the only site of disease.
boolean
C1522449 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C1515974 (UMLS CUI [2,3])
C0205171 (UMLS CUI [2,4])
C1705847 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C1515974 (UMLS CUI [2,3])
C0205171 (UMLS CUI [2,4])
ECOG performance status
Item
ecog performance status </= 2.
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of > 6 months
boolean
C0023671 (UMLS CUI [1])
Chemotherapy | Therapeutic radiology procedure
Item
chemotherapy or radiotherapy within 1 week of beginning treatment in the clinical trial
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
Metastatic malignant neoplasm to brain
Item
brain metastasis
boolean
C0220650 (UMLS CUI [1])
Thrombophlebitis | Deep Vein Thrombosis | Pulmonary Embolism
Item
prior history of or active thrombophlebitis, deep venous thrombosis or pulmonary embolus
boolean
C0040046 (UMLS CUI [1])
C0149871 (UMLS CUI [2])
C0034065 (UMLS CUI [3])
C0149871 (UMLS CUI [2])
C0034065 (UMLS CUI [3])
Vaginal Hemorrhage
Item
current vaginal bleeding
boolean
C2979982 (UMLS CUI [1])
Hypercalcemia | Hypocalcemia
Item
hypercalcemia or hypocalcemia
boolean
C0020437 (UMLS CUI [1])
C0020598 (UMLS CUI [2])
C0020598 (UMLS CUI [2])
Hepatocellular Adenoma
Item
history of or active hepatic adenoma
boolean
C0206669 (UMLS CUI [1])
Malignant Neoplasms | Exception Curative treatment Basal cell carcinoma | Exception Curative treatment Squamous cell carcinoma of skin | Exception Curative treatment Carcinoma in situ of uterine cervix
Item
no other malignancies within the past 5 years with the exception of curatively treated basal cell or squamous cell carcinoma of the skin or carcinoma in-situ of the cervix
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
C0007117 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1273390 (UMLS CUI [3,2])
C0553723 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C1273390 (UMLS CUI [4,2])
C0851140 (UMLS CUI [4,3])
C1705847 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
C0007117 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1273390 (UMLS CUI [3,2])
C0553723 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C1273390 (UMLS CUI [4,2])
C0851140 (UMLS CUI [4,3])